BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Society of Cannabis Clinicians
X-ORIGINAL-URL:https://www.cannabisclinicians.org
X-WR-CALDESC:Events for Society of Cannabis Clinicians
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Bogota
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220506T090000
DTEND;TZID=America/Los_Angeles:20220506T093000
DTSTAMP:20260603T221641
CREATED:20220421T141840Z
LAST-MODIFIED:20220421T141840Z
UID:10000103-1651827600-1651829400@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Presents Journal Club: "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!"
DESCRIPTION:Friday\, May 6\, 2022 at 9am PDT / 12pm EDT \nResearch Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!” \nSpeaker: Dr. Mihkail Kogan \nModerator: Zach Moore\, PhD \nEvent registration link: \nhttps://cannabisclinicians.tradewing.com/event/YsyEfdp5favrgo2r7 \nJoin us for an educational discussion with Mikhail Kogan\, MD as he highlights his recent research article “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.” \nLearn More About Mikhail Kogan: \n \nDr. Mikhail Kogan\, MD is a Medical Director\, GW Center for Integrative Medicine\, and the Assistant Professor\, George Washington University School of Medicine and Health Sciences. \nHe is an Integrative Medicine Fellowship Director\, Primary Care Internal Medicine\, Integrative Geriatrics\, Functional Medicine\, Integrative Palliative Care Physician. \nHe is also the founder and Executive Director of ex-officio\, of AIM Health Institute\, a 501 (c) (3) non-profit  organization \nDr. Kogan is a founding Board Member of the American Board of Integrative Medicine\, and a Board Member of the Art of Healing Foundation. \nDr Kogan is a leader in the newly-established field of Integrative Geriatrics. He is the chief editor of the first definitive textbook of the field entitled “Integrative Geriatric Medicine ”\, published by Oxford University Press as part of Andrew Weil Integrative Medicine Library series and is frequent speaker at a variety of international conferences on the topics of Integrative Medicine and Geriatrics\, healthy aging\, and geriatrics\, as well as neurodegenerative diseases\, and use of medical cannabis. Additionally\, he has published in both Integrative and Geriatric topics in leading US-based journals. \nDr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatrics Fellowship Program. He is the founder and director othe George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine\, as well as serving as part-time faculty member of the George Washington Institute for Spirituality and Health\, and the GW Center for Aging\, Health and Humanities. \nIn addition to his academic roles at George Washington University Dr. Kogan serves on a number of national boards and organizations including: the American Board of Integrative Medicine within the American Board of Physician Subspecialists (ABPS)\, ProCure Art\, PlantMed\, and others. Dr Kogan is also the founder and the chair of the board of AIM Health Institute\, a 501(c)(3) non-profit organization in the Washington\, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay. \nFor Dr. Mikhail Kogan\, the practice of medicine\, much like the rest of his life\, has been a journey spanning many miles and many cultures\, with valuable new learning and different perspectives accruing from each stage along the way. Those many experiences – here and abroad\, in the classroom and the clinic\, professionally and personally – have given Dr. Kogan the skills\, \, openness\, and inquisitiveness that set him apart\, and distinguish him as a committed and caring practitioner within integrative medicine. \nBorn in Moscow\, in the former Soviet Union\, Dr. Kogan emigrated with his family in his teens\, first to Israel\,and then to the United States\, where he obtained his medical degree from the Drexel University College of Medicine in Philadelphia\, Pennsylvania. He followed a Primary Care and Social Medicine Track residency in Internal Medicine at Montefiore Medical Center in New York City\, and a fellowship in Geriatric Medicine at the George Washington University Medical Center in Washington\, D.C.\, which led to a position as an assistant professor of medicine in the Division of Geriatrics and Palliative Care. \nIn addition to his training in conventional Western medicine\, Dr. Kogan has actively pursued a number of other healing arts and practices that have shaped his understanding of and approach to patient care. He is a graduate of a two-year training course in craniosacral therapy–a subtle osteopathic modality that has a wide range of effectiveness for different conditions such as headaches\, back pains\, and fatigue. He has also completed a four-year program at the Suluk Academy\, a teaching center based on the principles and traditions of Sufism\, where he learned how to incorporate meditation\, mindfulness\, and different spiritual practices into his daily life and his work with the patients. Among his many other areas of study are courses in Nutrition\, therapeutic use of vitamins\, Functional Medicine\, botanicals\, and other alternative modalities. \nWeaving those tools into the fabric of his medical practice has enabled Dr. Kogan to provide innovative and effective treatments to his patients with minimal use of invasive procedures or heavy reliance on medications and to understand the importance of self-exploration\, awareness and positive lifestyle changes as essential milestones on his patients’ journeys towards better health. Dr. Kogan is dedicated to helping patients with Alzheimer’s disease identify and correct underlying metabolic drivers work\, which is primarily based on Dr. Dale Bredesen’s research and newly created ReCode protocol. \nDr. Kogan practices Geriatric and Integrative Medicine in a variety of settings: at the George Washington Hospital\, at the GW Center for Integrative medicine\, as well as serving patients in home visits. \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-presents-journal-club-cannabis-consumption-used-by-cancer-patients-during-immunotherapy-correlates-with-poor-clinical-outcome/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-May-with-Mikahil-Kogan.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220415T110000
DTEND;TZID=America/Los_Angeles:20220415T123000
DTSTAMP:20260603T221641
CREATED:20220411T025604Z
LAST-MODIFIED:20220413T163300Z
UID:10000102-1650020400-1650025800@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Journal Club Presents: "State Medical Cannabis Programs: What Physicians Should Know And Consider" Hosted By Richard Cheng\, JD\, CHC
DESCRIPTION:Friday\, April 15\, 2022 at 11am PDT / 2pm EDT\n\nResearch Presentation: “State Medical Cannabis Programs: What Physicians Should Know And Consider”\n\nSpeaker: Richard Cheng\, JD\, CHC \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Richard Cheng\, JD\, CHC\, as we learn more about “State Cannabis Laws.” \n\nLearn More About Richard Cheng: \nRichard Cheng\, JD\, CHC \nRichard Cheng is a healthcare and cannabis regulatory and corporate attorney\, specializing in representing healthcare providers and cannabis businesses. He is also a healthcare professional holding a degree in Occupational Therapy (BSOT). \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-journal-club-presents-state-medical-cannabis-programs-what-physicians-should-know-and-consider-hosted-by-richard-cheng-jd-chc/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-with-Richard-Cheng-1.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220408T090000
DTEND;TZID=America/Los_Angeles:20220408T090000
DTSTAMP:20260603T221641
CREATED:20220301T044704Z
LAST-MODIFIED:20220315T141155Z
UID:10000101-1649408400-1649408400@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Dr. Lauren Streicher\, "The Use of Cannabinoids in Menopause"
DESCRIPTION:Event Description\n\nJoin us for the upcoming SCC Quarterly Meeting featuring Dr. Lauren Streicher as she shares her presentation on “The Use of Cannabinoids in Menopause.” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nLearn More About This Event:  \nThere are over 60 million menopause women in the United States\, and over 80% of those women experience debilitating  and life shortening symptoms such as hot flashes and insomnia. Only 7% get a prescription to relieve those symptoms since there is a persistent (and false) perception that estrogen is dangerous. Many post menopause women are turning to cannabis. Dr. Lauren Streicher\, a clinical professor of Obstetrics and Gynecology at the Feinberg School of Medicine\, Northwestern University\, and the Medical Director of the Northwestern Medicine Program for Menopause will discuss the potential role of cannabinoids in menopausal women. \nMeet Dr. Lauren Streicher: \n \nLauren Streicher\, MD is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine\, and the medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society\, a member of the Sexual Medicine Society of North America\, Inc.\, The International Society for the Study of Women’s Sexual Health\, and The Scientific Network on Female Sexual Health and Cancer. In addition to authoring multiple scientific publications\, she has written multiple consumer books. Her most recent releases are Slip Sliding Away: Turning Back the Clock on Your Vagina and Hot Flash Hell: A Gynecologist’s Guide to Turning Down the Heat. \nDr. Streicher is the medical correspondent for Chicago’s top-rated news program\, the WGN Morning News\, and has appeared multiple times on The Today Show\, Good Morning America\, The Oprah Winfrey Show\, CNN\, NPR\, Dr. Radio\, Nightline\, Fox and Friends\, The Steve Harvey Show\, CBS This Morning\, ABC News Now\, NBC Nightly News\, 20/20\, and World News Tonight. She lives in Chicago with her writer-producer husband\, Jason Brett\, and their dog\, KJ. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-dr-lauren-streicher-the-use-of-cannabinoids-in-menopause/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/Quarterly-meeting-with-Dr.-Streicher-IG-FB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220314
DTEND;VALUE=DATE:20220316
DTSTAMP:20260603T221641
CREATED:20220114T022112Z
LAST-MODIFIED:20220114T030711Z
UID:10000099-1647216000-1647388799@www.cannabisclinicians.org
SUMMARY:CannX-Tel Aviv
DESCRIPTION:CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists\, clinicians\, entrepreneurs\, investors\, policymakers\, and thought leaders for the ultimate opportunity to make an impact in the field. We haven’t had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel’s most cosmopolitan and vibrant city – Tel Aviv.
URL:https://www.cannabisclinicians.org/event/cannx-telaviv/
LOCATION:Tel Aviv\, Israel
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/01/CannX19-434-300x200-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220304T090000
DTEND;TZID=America/Los_Angeles:20220304T090000
DTSTAMP:20260603T221641
CREATED:20220208T221302Z
LAST-MODIFIED:20220301T211456Z
UID:10000100-1646384400-1646384400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Bonni Goldstein\, MD & Itzhak Kurek\, PhD - Cannabis-Responsive Biomarkers & Autism Spectrum Disorder
DESCRIPTION:March 4\, 2022 at 9am PST / 12pm EST\n\nArticle: Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.\n\nSpeakers: Bonni Goldstein\, MD & Itzhak Kurek\, PhD \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Bonni Goldstein\, MD & Itzhak Kurek\, PhD moderated by Zach Moore\, PhD as we discover their newest publication\, “Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.” \nAutism spectrum disorder (ASD) is a group of neurodevelopmental conditions that impact behavior\, communication\, social interaction\, and learning abilities. Treatment of ASD with medical cannabis (MC) shows promising results in reducing the severity of certain behavioral aspects. The goals of this observational study are to demonstrate the potential of metabolic biomarkers to (1) objectively determine the impact on metabolites of MC treatment and (2) suggest the metabolic pathways of children with ASD\, who respond to MC treatment. \n\nLearn More About Dr. Bonni Goldstein: \nDr. Bonni Goldstein \nBonni Goldstein\, MD is the Medical Director of Canna-Centers Wellness & Education\, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions.  She completed her internship and residency at Children’s Hospital Los Angeles\, where she also served as chief resident.  After years of working in the specialty of Pediatric Emergency medicine\, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend.  Over the last 13 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics.  She has a special interest in treating children with intractable epilepsy\, autism\, cancer and other conditions. Her latest book\, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little\, Brown Spark. Dr. Goldstein recently co-authored a peer-reviewed article researching the use of Cannabis-Responsive biomarkers to document cannabis treatment efficacy\, guide clinical decision-making and improve outcomes. \n\nLearn More About Itzhak Kurek\, PhD: \nItzhak Kurek\, PhD \nItzhak Kurek\, PhD is the co-founder and CEO of Cannformatics\, Inc. a San Francisco-based biotechnology startup developing saliva-based Cannabis-Responsive™ biomarkers as a universal tool for the objective measurement of the physiological impact of any cannabinoid-based treatment. He has executive and research management experience in the Ag-Biotech\, Nutritional Supplements and Biobased Products businesses. Previously he held positions at Solix Algredients\, Kiverdi\, Pioneer Hi-Bred (DuPont) and Maxygen. He has published over 70 peer-reviewed scientific papers and patents. Dr. Kurek received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California\, Davis. Dr. Kurek has also conducted research at the Technical University of Munich\, John Innes Center Norwich\, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories. \n  \nREGISTER TO ATTEND
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-bonni-goldstein-md-itzhak-kurek-phd-cannabis-responsive-biomarkers-autism-spectrum-disorder/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/CannaTalk-with-Dr.-Goldstein-Kurek-IGFB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220127
DTEND;VALUE=DATE:20220130
DTSTAMP:20260603T221641
CREATED:20220112T184549Z
LAST-MODIFIED:20220112T192920Z
UID:10000098-1643241600-1643500799@www.cannabisclinicians.org
SUMMARY:Cannabis Science & Industry Congress
DESCRIPTION:January 27-29\, 2022 | San Jose\, Costa Rica \nThe Cannabis Congress has partnered with the Society of Cannabis Clinicians to develop the Medical Track of the event featuring clinicians and researchers presenting the latest research and clinical findings on the therapeutic applications of cannabis. Doctors from Latin America\, the United States\, the EU\, and Canada will be addressing an array of the most sought-after clinical topics from pain\, sleep\, epilepsy\, mental health and more\, to clinician activism\, historical perspectives and indigenous knowledge of cannabis medicine. \n  \nMORE INFO >> \n  \n 
URL:https://www.cannabisclinicians.org/event/cannabis-science-industry-congress/
LOCATION:Parque Viva Main Gate\, Alajuela\, Costa Rica
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/cannabis-for-tic-disorders.png
ORGANIZER;CN="Cannabis Science and Industry Congress":MAILTO:info@thecannabiscongress.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220113T090000
DTEND;TZID=America/Los_Angeles:20220113T100000
DTSTAMP:20260603T221641
CREATED:20211207T103115Z
LAST-MODIFIED:20220112T181310Z
UID:10000097-1642064400-1642068000@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Dr. Josh Kaplan on CBD Exposure and Behavioral Changes in Mice
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Josh Kaplan discuss a paper on adolescent CBD exposure in mice not having substantive negative impacts on a range of behaviors in adulthood. It may also improve the rate of learning under certain conditions. \nPresenter:\nDr. Josh Kaplan \nArticle to be Discussed:\n\nCannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity\, Anxiety\, and Spatial Memory\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDr. Josh Kaplan Josh Kaplan earned his Ph.D. in Behavioral Neuroscience in 2015 from Oregon Health & Science University and then joined the University of Washington for two postdoctoral fellowships where he trained in cannabinoid pharmacology. His work has contributed towards our understanding of the therapeutic potential of phytocannabinoids and the body’s endocannabinoid system. Dr. Kaplan’s research was instrumental in demonstrating the effectiveness of cannabidiol (CBD) as a monotherapy in treating medically-refractory seizures and improving autism-like social interaction deficits using pre-clinical genetic models of disease. Further\, he utilized his expertise in electrophysiology and pharmacological techniques to demonstrate a significant non-endocannabinoid mechanism-of-action by which CBD achieves its therapeutic relevance. His later studies focused on the therapeutic utility of enhancing endocannabinoid function and the relevant interactions with other inhibitory systems in the brain. \nDr. Kaplan is currently an Assistant Professor of Behavioral Neuroscience at Western Washington University in Bellingham\, WA\, where he trains undergraduate and graduate students in his cannabis research lab. By utilizing animal behavioral\, molecular\, pharmacological\, and electrophysiological techniques\, the Kaplan lab is working to identify ways of improving the plant’s therapeutic benefits and safety across a range of conditions. Their aim is to identify optimized cannabinoid and terpene compositions that extend the therapeutic dosing range while bolstering efficacy and limiting adverse effects. \nBeyond the lab\, Dr. Kaplan is a devoted mentor\, educator\, and science communicator. He has contributed numerous articles to peer reviewed journals\, book chapters\, as well as written for websites and magazines including High Times\, Cannabis and Tech Today\, and Leafly. He’s also spoken internationally on cannabis science for all types of audience and consulted for documentaries and popular science books. He was included in High Times’ 100 Most Influential People in Cannabis in 2018.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dr-josh-kaplan/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/JournalClub-with-Dr.-Kaplan-Cseq-IgFb-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211216T090000
DTEND;TZID=America/Los_Angeles:20211216T103000
DTSTAMP:20260603T221641
CREATED:20211012T141021Z
LAST-MODIFIED:20211213T094652Z
UID:10000095-1639645200-1639650600@www.cannabisclinicians.org
SUMMARY:Cannabis & Psychedelics Webinar
DESCRIPTION:Join us for the inaugural Cannabis & Psychedelics Webinar put on by the Society of Cannabis Clinicians is co-hosting with the Psychedelic Medicine Association. \nThe event will focus on highlighting the psychedelic effects of cannabis and the therapeutic approaches of how cannabis can be used in conjunction with psychedelics (for example\, in between psychedelic-assisted therapy sessions to prolong the therapeutic benefits or within sessions to enhance effects\, etc.). The webinar will also focus on research on how psychedelics engage with the endocannabinoid system. The featured speakers will highlight their work in the field of psychedelic medicine to provide information on how clinicians can get training to utilize entheogens in their clinical practice. \nSpeakers & Topics: \n\nDustin Sulak\, DO: Beyond the Crutch and the Tonic: Cannabis as a Teacher\nSaj Razvi\, LPC: Cannabis & the Autonomic Nervous System: A Preferential Pathway for Psychedelic Therapy\nRebecca Kronman\, LCSW: Facing stigmas of medical cannabis and psychedelic-assisted therapies for clinicians and patients\nMark Braunstein\, DO\, ABPN: Psychiatric and medical considerations\, cannabis dosing as part of ketamine protocols\nMatthew Campeau\, LPC: Preventing and working with psychedelic crises\, thresholds and safety planning\n\nFurther info on each speaker can be found in their bio below. \nFree for SCC members\, $25 for non-members \n  \nRSVP >> \n  \nDustin Sulak\, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis\, the author of the first foundational text on its clinical use\, Handbook of Cannabis for Clinicians: Principles and Practice\, and a co-founder of Healer.com\, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis\, and serves on the board of directors of The Society of Cannabis Clinicians. \n  \nSaj Razvi\, LPC is the founder and Director of Education at Psychedelic Somatic Institute. He was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy. He is faculty at Mind Medicine Australia and formerly taught PTSD studies at the University of Denver. He is the primary developer of the Psychedelic Somatic Interactional Psychotherapy (PSIP) modality which is a next generation non-ordinary state psychotherapy that maximizes the relational and autonomic healing capacity of psychedelic medicine to treat complex\, childhood developmental trauma. His primary focus is to train clinicians to provide legal\, effective psychedelic treatment in their private practice settings utilizing readily accessible medicines such as cannabis and ketamine. Click here to view an actual psychedelic therapy session using PSIP and cannabis. \n  \n  \n  \nRebecca Kronman\, LCSW is a licensed therapist and founder of Plant Parenthood\, a digital and in-person community of parents who use psychedelics. She is also an assisting trainer with Fluence\, a company that trains healthcare practitioners in harm reduction informed psychedelic preparation and integration. At her private practice in Brooklyn\, she works with clients using mindfulness\, experiential techniques and ketamine assisted psychotherapy to address depression\, anxiety and life transitions. She also helps clients prepare for psychedelic experiences\, incorporate insights or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress Reduction\, Mindfulness for Clinicians\, Psychedelics 101 & 102 and Beyond Experience Psychedelic Integration Workshop. Outside of work\, she is a mother of two boys ages 5 and 7. \n  \n  \n  \nMark Braunstein\, DO\, ABPN Matthew trained as a psychotherapist at Naropa University in Transpersonal Counseling Psychology. He has been an Independent Rater with the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2012\, currently supporting Phase 3 MDMA Assisted Psychotherapy studies. Matthew has trained in Ketamine Assisted Psychotherapy with the Ketamine Training Center. He has worked with thousands of suicidal and high acuity clients and is passionate about harm reduction and prevention. Matthew has 12 years clinical experience with individuals with mild to chronic and severe mental illnesses and has a strong ability to remain grounded and support clients in dysregulation\, crisis\, psychosis\, or altered states of consciousness. In addition to developing psychedelic psychotherapy protocols\, he practices ketamine and cannabis-assisted psychotherapy. \n  \n  \n  \n  \nMatthew Campeau\, LPC “Dr. B\,” is a whole health psychiatrist. He completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry in 1997. Shortly thereafter\, he began exploring the use of psychoactive plant-based medicines in the treatment of various psychiatric conditions in both children and adults. With over 22 years of clinical experience\, Dr. B has pioneered a new path in psychiatric care that integrates wilderness programming\, exercise\, diet\, spirituality\, and natural medicines. Dr. B is the medical director for multiple mental health clinics\, including a groundbreaking psychedelic psychotherapy practice in Durango\, Colorado. His plant-based dosing protocols have made him a sought-after medical consultant\, advisor\, and educator. With a focus on expanding access\, awareness\, research\, and safety in the field of psychedelics\, Dr. B champions innovative technology and telemedicine at his company Reconscious Medical. His mission is to create tailored solutions that empower patients to live full\, happy\, unencumbered lives.
URL:https://www.cannabisclinicians.org/event/cannabis-psychedelics-webinar/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/10/Cannabis-Psychedelic-Medicine-Webinar-web-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211208T090000
DTEND;TZID=America/Los_Angeles:20211208T103000
DTSTAMP:20260603T221641
CREATED:20210929T135028Z
LAST-MODIFIED:20211206T085212Z
UID:10000094-1638954000-1638959400@www.cannabisclinicians.org
SUMMARY:SCC International Veterinary Alliance Webinar: Dosing & Administration
DESCRIPTION:9-10:30am PST / 11am-12:30pm CST / 12-1:30pm EST / 5-6:30pm BST  \nJoin an international lineup of experts exploring how veterinarians approach the philosophy of dosing and the main considerations when creating a treatment plan for animal patients. The SCC International Veterinary Alliance Webinar is open to anyone interested in the applications of cannabis in veterinary practice. \nTopic:\nCannabis Dosing and Administration Strategies in Veterinary Medicine \nSpeakers (bios below):\n\nSantiago Acosta\, DVM – (Colombia)\nRafael Ricardo Santisteban-Arenas\, DVM (Colombia)\nErik Almeida\, DVM (Brazil)\nTrina Hazzah\, DVM (USA)\nGary Richter\, DVM (USA)\nConny Mosley\, DVM (Canada)\nSarah Silcox\, DVM (Canada)\n\nFree for SCC members\, $10 for non-members \n  \nRSVP >> \n  \n Trina Hazzah\, DVM was born and raised in Washington DC. She attended Tuskegee University School of Veterinary Medicine where she earned her Doctor of Veterinary Medicine in 2006. She has also completed the requirements to be a Certified Veterinary Chinese Herbalist from the Chi Institute of Traditional Chinese Veterinary Medicine. Dr. Hazzah developed an interest in cannabis medicine during her quest for finding effective integrative approaches for veterinary cancer patients. She has spent the last half a decade reading through available literature\, attending multiple cannabis conferences and symposiums\, while also learning from cannabis physicians.  She is is the president and co-founder of the Veterinary Cannabis Society\, which is the first US-based non-profit\, 501(c)(3) organization building awareness of cannabis as medicine for pets. \n  \n  \n  \n  \nDr. Gary Richter has been practicing veterinary medicine in the SF Bay Area since 1998. He is certified in acupuncture\, chiropractic\, and Western herbology. Dr. Richter’s practice focuses on the benefits of conventional and holistic treatment methods for the preventative and therapeutic care of pets as well as educating professionals and pet owners on the benefits of integrative care. Dr. Richter was named Holistic Veterinarian of the Year for 2019 by the American Holistic Veterinary Medical Association\, is currently the President of the American College of Veterinary Botanical Medicine\, and is a founding member of the Veterinary Cannabis Society. \n  \n  \n  \n \n\nSantiago Acosta Colmenares\, DVM is the CEO of ENDOVET and the President of the Latin American Veterinary Medicine Association. He is currently a professor of medicinal cannabis at the National University of Colombia\, University of Rosario\, and University of Caldas. He is a member Society of Cannabis Clinicians (SCC) and Canadian Association of Veterinary Cannabinoid Medicine (CAVCM). He is also an advisor to the Colombian Agricultural Institute on issues related to medicinal cannabis in veterinary medicine. He is an international speaker on Medicinal Cannabis and entheogens in veterinary medicine and also designs cannabis-based products.\n \n \n \n \n \n \n  \n Dr. Sarah Silcox is a pioneer in the world of veterinary cannabis use and is one of the founding directors and the current President of the Canadian Association of Veterinary Cannabinoid Medicine. An OVC ‘97 grad\, she is a small animal veterinarian with over 20 years of clinical experience. Dr. Silcox has been active in general\, locum\, and emergency practice\, founded her region’s first integrative medicine practice\, and is currently operating her region’s first veterinary practice dedicated solely to palliative\, hospice\, and end-of-life care for pets. A passionate advocate for the veterinary use of cannabis and cannabinoid medicine\, her interest in the potential benefits of medical cannabis for pets reaches back several years. With changes in legislation that legalized cannabis in Canada\, she is grateful to now be able to guide her clients on the responsible use of cannabis for treating their pets and has seen numerous patients that have benefited from the therapeutic effects of this amazing plant.\n \n \n \n \n \nDr. Erik Amazonas is an Associated Professor of Veterinary Medicine at the Federal University of Santa Catarina. Dr. Amazonas was the first to include classes of endocannabinology in a veterinary school in Brazil in 2018. Dr. Erik collaborates with several universities and non profit organizations in Brazil and worldwide and is a member of the Veterinary Cannabis Society.\n \n \n \n  \n  \n \n  \n Dr. Cornelia (Conny) Mosley is a boarded anesthesiologist working as a Veterinary Consultant in Orthopedic Health and Pain for Elanco Canada as well as providing care for chronic pain patients in her Integrative Veterinary Pain Clinic at VCA Canada\, 404 Veterinary Emergency and Referral Hospital in Newmarket\, north of Toronto. She has a strong interest in pain management\, in particular in the integrative and collaborative approaches to pain relief. Conny is certified in veterinary acupuncture. Dr. Mosley is also the founding director and vice president of the Canadian Association of Veterinary Cannabinoid Medicine\, an organization that helps understand\, educate and collaborate in research in cannabinoid medicine and it’s role in veterinary medicine. \n  \n  \n Rafael Ricardo Santisteban-Arenas\, DVM is a DVM and MSc from Universidad de Caldas en Colombia. He is currently an Assistant Professor Institución Universitaria Visión de las Américas\, Pereira and Medical Coordinator Veterinary Clinic Institución Universitaria Visión de las Américas\, Pereira. He is also a Veterinary Advisor for Khiron Life Sciences Corp and Member of Red Cannabis Medicinal Veterinaria\, Colombia. His research publications include chronic gastrointestinal conditions\, cannabinoid therapy in small animals\, infectious diseases and palliative care.
URL:https://www.cannabisclinicians.org/event/scc-international-veterinary-alliance-webinar-dosing-administration/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/Veterinary-Alliance-Webinar-Banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211118T150000
DTEND;TZID=America/Los_Angeles:20211118T163000
DTSTAMP:20260603T221642
CREATED:20210929T082312Z
LAST-MODIFIED:20211020T162637Z
UID:10000092-1637247600-1637253000@www.cannabisclinicians.org
SUMMARY:Navigating The Complexities of Autism & Cannabis: Facts vs. Myths
DESCRIPTION:3-4:30pm PST\, 6-7:30pm EST \nThe SCC is hosting an event to highlight the complexities of autism and cannabis\, while dispelling fact vs. myth among this clinical research topic. \nThis free event on Thursday\, November 18th will serve as an educational resource for both clinicians and patients/caregivers as they explore the complexities and challenges associated with autism spectrum disorder and the use of medical cannabis. During the event\, our panelists will be sharing their clinical research insight\, while breaking down the facts versus myths surrounding ASD and medicinal cannabis. A Q&A session will also take place. Our speaker and panelist line up includes the following: \nFeatured Keynote Speaker– Patricia Frye\, MD\nHost: Sherry Yafai\, MD\nModerator: Minchul An\, PharmD \nPanelists: \n\nBonni Goldstein\, MD\nDustin Sulak\, DO\nDr. Muhsinah Morris\nMelani Kane\, PharmD\nGenesis A. Emery\n\nREGISTER >>
URL:https://www.cannabisclinicians.org/event/autism/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/SCC-Autism-Event-WEB-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Bogota:20211115T100000
DTEND;TZID=America/Bogota:20211121T170000
DTSTAMP:20260603T221642
CREATED:20211102T080949Z
LAST-MODIFIED:20211102T081032Z
UID:10000096-1636970400-1637514000@www.cannabisclinicians.org
SUMMARY:Vetcann On Line: Congreso Internacional De Cannabis Medicinal En Veterinaria
DESCRIPTION:Participa en el Congreso Anual: VETCANN 2021 Congreso Internacional de Cannabis en Medicina Veterinaria. \nNos complace hacerte parte de este encuentro de Educación\, Investigación y Desarrollo del Cannabis en Veterinaria por tercer año consecutivo\, de la mano de los mejores y con el apoyo de importantes entidades del gremio veterinario y del Cannabis en el mundo. \n\nMás de 30 conferencistas\n10 Salas temáticas\nMás de 10 países\n6 días de encuentro\n\nPara mayor información puedes hacer un preregistro en el siguiente link: \nRegistrarme >>
URL:https://www.cannabisclinicians.org/event/vetcann-on-line-congreso-internacional-de-cannabis-medicinal-en-veterinaria/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/11/cannabis-Veterinaria.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211111T170000
DTEND;TZID=Europe/London:20211111T180000
DTSTAMP:20260603T221642
CREATED:20210920T155753Z
LAST-MODIFIED:20210921T134112Z
UID:10000090-1636650000-1636653600@www.cannabisclinicians.org
SUMMARY:Leading with Real-World Evidence: UK medical cannabis outcomes and global opportunities
DESCRIPTION:11th November 2021 – 9am PST\, 12pm EST\, 5pm GMT\, 18h CET \nThe Society of Cannabis Clinicians UK Chapter welcomes Sapphire Medical Clinics\, the UKs first and highest rated medical cannabis clinic\, to present “Leading with Real-World Evidence” on November 11th . Sharing the importance of Real-World Evidence in the global use of cannabis based medicines\, leading UK experts highlight what they’ve learnt so far\, and how to get involved. \nPart 1: The growth of Real-World Evidence in medical cannabis \nPart 2: Prescribing outcomes from the UK Medical Cannabis Registry \nPart 3: International collaboration opportunities \nRegister below for the free virtual event: Healthcare professionals and interested parties are welcome to join the 1 hour session. \nSpeakers\nDr. Mikael Sodergren is Managing Director and Academic Lead at Sapphire Medical Clinics\, the UK’s first and highest rated medical cannabis clinic. He is also an academic clinician and consultant hepatobiliary and pancreatic surgeon at Imperial College London\, where he leads a medical cannabis research programme. \nDr. Simon Erridge is Head of Research and Access at Sapphire Medical Clinics. Dr Erridge is also an honorary clinical research fellow at Imperial College London and junior doctor in North West London. \nDr. Ross Coomber is Operations Director at Sapphire Medical Clinics. As a Consultant Trauma and Orthopaedic Surgeon\, Dr Coomber completed a 12 month trauma fellowship in Canada where he first gained experience of working with medical cannabis. \nREGISTRATION >>
URL:https://www.cannabisclinicians.org/event/leading-with-real-world-evidence-uk-medical-cannabis-outcomes-and-global-opportunities/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/Sapphire-Institute-Society-of-Cannabis-banner-V2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211105T090000
DTEND;TZID=America/Los_Angeles:20211105T100000
DTSTAMP:20260603T221642
CREATED:20210908T161749Z
LAST-MODIFIED:20210909T090225Z
UID:10000088-1636102800-1636106400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Mariana Maciel\, MD on Water-soluble Nano-enhanced Cannabinoid Medicines
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Maciel discuss evidence about water-soluble nano-enhanced cannabinoid medicines and their applicability\, safety and how they differ from oil products. \nPresenter:\nMariana Maciel\, MD (bio below) \nTopic:\nWater-soluble Nano-enhanced Cannabinoid Medicines \nArticle to be Discussed:\n\nTowards Better Delivery of Cannabidiol (CBD)\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nMariana Maciel\, MD is a physician graduated at the Faculty of Medicine of Barbacena and completed her residency in Internal Medicine. She worked in Brazil in clinical ward\, urgency / emergency\, SAMU (paramedic)\, intensive care\, and family medicine. She worked with research\, article publishing and attended an internship at Charles University (CZ). She also has teaching experience at Universidade Federal de Viçosa. \nAlthough she was progressing in her medical career in Brazil\, Dr. Mariana chose to move to Canada in search of new opportunities and a better quality of life. In Canada\, in addition to getting married and becoming a mother\, she leveraged her career by specializing in Medicinal Cannabis and Cannabinoid Medicine. In Vancouver\, she is part of a Medicinal Cannabis clinic team. Her entrepreneurial profile added to her values of holistic and integral medicine which gave rise to Thronus Medical and Thronus Education. Dr. Mariana has put into practice her mission to transform and inspire people’s lives through medical education and the development of innovative cannabis-derived products.
URL:https://www.cannabisclinicians.org/event/journal-club-mariana-maciel-md-on-water-soluble-nano-enhanced-cannabinoid-medicines/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211014T090000
DTEND;TZID=America/Los_Angeles:20211014T100000
DTSTAMP:20260603T221642
CREATED:20210929T134028Z
LAST-MODIFIED:20211001T074250Z
UID:10000093-1634202000-1634205600@www.cannabisclinicians.org
SUMMARY:Legal Concerns for the Cannabis Healthcare Professional
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nWith cannabis remaining classified as a Schedule I drug under the federal Controlled Substances Act in the United States\, legal concerns for clinicians practicing cannabinoid medicine remain high. Join us for this informational session when SCC member Richard Cheng\, JD CHC will share what he has learned about the issues that healthcare professionals face when entering this clinical realm. \nThe SCC is excited to announce the alliance with INCBA (the International Cannabis Bar Association)\, a membership organization led by Christopher Davis. Their mission is to raise the standard of legal services available to the cannabis industry\, to advocate for the lawyers’ right to represent cannabis industry participants\, and to help build a solid foundation upon which the cannabis industry can sustainably thrive for years to come. Through our alliance\, SCC will serve as a resource to INCBA members providing research studies and medical expertise for clinical cases. Also INCBA members will address questions from SCC members facing legal issues and provide pro bono support when available. \nPresenters:\n  \nChristopher Davis\, Esq\nExecutive Director\, International Cannabis Bar Association\nPartnership announcement of SCC & INCBA; History and goals of INCBA \nRichard Cheng\, JD\, CHC\nHealthcare Attorney with Speciality in Cannabis \nTopics to be discussed:\nOverview of the current legal status for cannabis: \n\nHow cannabis is viewed by the public\nFederal and state prohibitions\nFederal protections\nPhysician concerns with cannabis\nLegal concerns and practices by facility based providers\nHealthcare fraud issues in cannabis\nAncillary concerns (e.g. contracts\, banking\, leases)\n\nFREE for SCC members. $10 for non members.  \n  \nREGISTRATION >>
URL:https://www.cannabisclinicians.org/event/legal-concerns-for-the-cannabis-healthcare-professional/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/pexels-photo-5668481.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211010T120000
DTEND;TZID=America/Los_Angeles:20211010T140000
DTSTAMP:20260603T221642
CREATED:20210924T085737Z
LAST-MODIFIED:20210928T095446Z
UID:10000091-1633867200-1633874400@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: The International Phytomedicine and Medical Cannabis Institute: High Impact Areas and Opportunities for Collaboration with Wilfred Ngwa\, MS\, PhD
DESCRIPTION:Join us for our quarterly meeting with featured speaker Wilfred Ngwa\, MS\, PhD. Dr. Ngwa will be discussing The International Phytomedicine and Medical Cannabis Institute: High impact areas and opportunities for collaboration with the USA. You may learn more about Dr. Ngwa’s work in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nWilfred Ngwa\, MS\, PhD has won 17 prestigious awards and honors over the past five years from Harvard\, the United States National Institutes of Health\, and international professional societies and organizations for his leading efforts in global health. His work has led to the establishment of new healthcare institutions and cancer centers in low and middle income countries. He has also trained thousands of healthcare professionals\, and established win-win collaborations for global health and economic development. He also is: \n\nDirector of the International Phytomedicine and Medical Cannabis Institute launched at Harvard in 2019\nA Distinguished Professor of Public Health ICT\nDirector of the Global Health Catalyst at Johns Hopkins and founding Director of the same program launched at Harvard Radcliffe institute in 2015 with afocus on catalyzing high impact collaborations for global health and development\nChair of the Lancet Oncology Commission for Sub-Saharan Africa\nFounder of the Global Oncology University\, an award-winning collaborative education model that offers everyone access to the same world class education and training available from professors at the world’s best institutions.\nCo-Director of the Africa-Oxford-Harvard (AfrOX-H) Clinical Trials network\nCurrently serves as Advisor for the USA government on Global Health
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-international-phytomedicine-and-medical-cannabis-institute-at-harvard-with-wilfred-ngwa/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211001T090000
DTEND;TZID=America/Los_Angeles:20211001T100000
DTSTAMP:20260603T221642
CREATED:20210915T152032Z
LAST-MODIFIED:20210921T132607Z
UID:10000089-1633078800-1633082400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Dylan Zylla\, MD on Cannabis for Stage IV Cancer- Dosage\, Safety\, and Impact on Pain
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear from Dylan Zylla\, MD as he discusses the applications of cannabis for stage IV cancer\, dosing\, the impact on pain\, and patient safety. \nPresenter:\nDylan Zylla\, MD (bio below) \nTopic:\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction. \nArticle to be Discussed:\n\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDylan Zylla\, MD is a hematologist/oncologist working to answer key questions in clinical oncology and improve pain and symptom management among patients with cancer. He integrates research into his clinical practice with protected research time and access to an institution with a strong reputation in quantitative\, qualitative and clinical research. He is a site principal investigator on multiple industry-sponsored oncology clinical trials. His projects focus on cancer pain\, the mu-opioid receptor\, and novel ways to treat pain. He was a key member of the Minnesota Community Measurement’s work group that developed quality measures for cancer symptom control using patient-reported outcomes (PROs)\, and he collaborates with national leaders on integrating electronic PROs into cancer care. \nSince 2016\, Dr. Zylla has spearheaded large-scale efforts to address how cannabis impacts the lives of patients with cancer. He led the Cannabis in Cancer (CanCan) study which randomized patients with metastatic cancers to receive early vs delayed cannabis to treat symptoms. In 2018\, he published a survey of medical oncology professionals in Minnesota and demonstrated most clinicians support cannabis use for their patients. In collaboration with the Minnesota Department of Health\, he analyzed surveys of over 1\,000 patients with cancer\, certified in the state’s cannabis program since 2015. They found that those patients experienced significant clinical improvement in a variety of symptoms and reported few serious adverse events. \nRecently completed projects:\n• A randomized trial of cannabis in patients with stage IV cancers to assess dose requirements\, impact on pain and opioid use\, and overall patient satisfaction.\n• Impact of pain\, opioids\, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer. This project developed a novel immunohistochemical assay to determine the level of a mu-opioid receptor on a cancer cell. \nProjects in development include:\n• Cannabis registry on experience using cannabis\, including over-the-counter cannabidiol (CBD)\n• Topical cannabis/CBD creams for pain\n• Impact of medical cannabis for patients with newly diagnosed\, stage IV pancreas cancer\n• Cannabis as an anti-cancer agent\n• Mu-opioid receptor expansion project\n• Improving assessment and management of hyperglycemia in patients with diabetes and cancer
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dylan-zylla-on-cannabis-for-stage-iv-cancer-dosage-impact-on-pain-and-safety/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210923T090000
DTEND;TZID=America/Los_Angeles:20210923T100000
DTSTAMP:20260603T221642
CREATED:20210811T151340Z
LAST-MODIFIED:20210811T151340Z
UID:10000087-1632387600-1632391200@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis for Health Promotion & Disease Prevention with Dustin Sulak\, DO
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the September edition of “Canna Talk with Frye and Wilson-King” on September 23rd as we explore cannabis for health promotion and disease prevention with Dustin Sulak\, DO.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Sulak and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Sulak presented in his SCC Clinical Training Module Cannabis for Health Promotion & Disease Prevention. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \n \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-for-health-promotion-disease-prevention-with-dustin-sulak-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210827T090000
DTEND;TZID=America/Los_Angeles:20210827T100000
DTSTAMP:20260603T221642
CREATED:20210526T131956Z
LAST-MODIFIED:20210526T132358Z
UID:10000084-1630054800-1630058400@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis in Geriatrics with Mikhail Kogan\, MD
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the August edition of “Canna Talk with Frye and Wilson-King” on August 27th as we explore cannabis in geriatrics and assisted living with Mikhail Kogan\, MD.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Kogan and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Walsh presented in his SCC Clinical Training Module Cannabis in Geriatrics & Assisted Living. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nMikhail Kogan\, MD\, ABOIM is board-certified in Internal Medicine\, Geriatrics\, Palliative Care\, and Integrative Medicine. Dr. Kogan is a leader in the newly established field of Integrative Geriatrics.  He is the editor of “Integrative Geriatric Medicine” Oxford University Press textbook. He is board-certified in Internal Medicine\, Geriatrics\, Palliative Care\, and Integrative Medicine. Dr Kogan is currently serves as medical director of the GW Center for Integrative Medicine\, associate director of the Geriatric and Integrative Medicine Fellowships at the George Washington University School of Medicine.  Dr Kogan has been early adopter of DC Medical Cannabis program and has been instrumental in DC Rx Medical Cannabis education program.  Dr Kogan is a frequent speaker at a variety of international conferences and has multiple media appearances related to medical cannabis. At present Dr Kogan is conducting pilot research program on assessing non psychoactive forms of cannabis such as CBD and CBDa for neurodegenerative conditions such as Alzheimer’s and Parkinson’s Diseases.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-in-geriatrics-with-mikhail-kogan-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210820T090000
DTEND;TZID=America/Los_Angeles:20210820T103000
DTSTAMP:20260603T221642
CREATED:20210526T080619Z
LAST-MODIFIED:20210714T064837Z
UID:10000081-1629450000-1629455400@www.cannabisclinicians.org
SUMMARY:Special Edition of Journal Club: Dr. Ethan Russo & Nishi Whiteley on Cannabinoid Hyperemesis Syndrome
DESCRIPTION:9-10am PST / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nPresenters: \n\nEthan Russo\nNishi Whiteley\n\n(read their bios below) \nTopic: \nCannabinoid Hyperemesis Syndrome: An Emerging Public Health Problem with a Genetic Basis \nArticle: \nCannabinoid Hyperemesis Syndrome Survey and Genomic Investigation (Cannabis and Cannabinoid Research\, 2021) \nOverview \nIs cannabinoid hyperemesis syndrome (CHS) associated with genetic mutations that might explain its unusual pathophysiology\, symptoms\, and signs? This topic is what Ethan Russo\, MD and Nishi Whiteley will be discussing in this special edition of Journal Club on August 20th. Their presentation will center around the findings\, implications\, and what the research illuminates about the daily life\, habits and susceptibilities of CHS patients based on their recent paper “Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation”. This event marks the first time that Dr. Russo and Nishi Whiteley will be presenting their findings to a physicians’ group. \nThe largest survey of CHS to date (205 CHS patients plus 54 controls after screening) was conducted by Dr. Russo and colleagues that confirmed clinical patterns of nausea\, vomiting\, abdominal pain\, and hot water bathing behavior associated with chronic high tetrahydrocannabinol (THC) exposure. Genomic testing in 28 CHS patients with firm diagnosis and ongoing associated symptoms vs. 12 controls who used cannabis but did not display symptoms and signs revealed five statistically significant mutations affecting TRPV1\, CYP2C9 coding the catabolic enzyme of THC\, DRD2 and COMT\, two genes affecting dopaminergic function\, and ABCA1\, the ATP-binding cassette transporter affecting cholesterol efflux. \nMeaning: These results establish a genetic etiology of susceptibility to development of CHS with high level THC exposure\, elucidate the associated pathologies of CHS\, and may represent a practical screening device that could point to more effective therapeutic interventions. Have the opportunity to ask questions and delve into the research with the authors of this exciting new research paper. \nThe event is FREE for SCC members. $10 for non members. \n  \nREGISTER >> \n  \n \nEthan Russo\, MD is a board-certified neurologist\, psychopharmacology researcher\, and author. He is the Founder and CEO of CannabisResearch.org. He has 24 years of clinical cannabis research experience. He has authored 50+ peer-reviewed journal articles and seven books. \nPreviously\, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague\, Czech Republic\, Medical Director of PHYTECS (2015-2017)\, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system\, and from 2003-2014\, he served as Senior Medical Advisor\, medical monitor and study physician to GW Pharmaceuticals\, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy. \nHe has held faculty appointments in Pharmaceutical Sciences at the University of Montana\, in Medicine at the University of Washington\, and as visiting professor\, Chinese Academy of Sciences\, Harvard University\, and Johns Hopkins University. \nHe is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs\, co-editor of Cannabis and Cannabinoids: Pharmacology\, Toxicology and Therapeutic Potential\, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics\, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS\, Women and Cannabis: Medicine\, Science and Sociology\, Cannabis: From Pariah to Prescription\, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters\, and over fifty articles in neurology\, pain management\, cannabis\, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms\, phytopharmaceutical treatment of migraine and chronic pain\, herbal synergy and phytocannabinoid/terpenoid\, serotonergic and vanilloid interactions. \nHe has consulted or lectured on these topics in 39 US states and Canadian provinces and 39 countries. \nNishi Whiteley (pronounced Nee-sha)\, is the co-founder and Chief Operating Officer of CReDO.  She has twenty-five plus years of international business development experience in cannabis\, agriculture\, wellness\, green energy\, and food industries. She has had leadership roles on projects in corporate America and for the US Foreign Ag Service in over 10 countries\, in startups\, a state agency and non-profits; as well as worked for foreign governments and met with international leaders in Cuba\, Mexico\, and the Dominican Republic to open trade and advance development programs.  She has worked on investment projects in 8 countries. \nA lay expert in medical cannabis\, she is the author of the book Chronic Relief: A Guide to Cannabis for the Terminally & Chronically Ill and the curator of the informational website MyChronicRelief.com. Whiteley lives in Texas where she is an advocate for cannabis law reform and sits on the board of the Foundation for an Informed Texas\, a cannabis advocacy organization. Whiteley has been a contributing writer at ProjectCBD and is a speaker/educator dedicated to helping patients and caregivers bridge the gap between cannabis science and safe practical application.  Whiteley became a cannabis advocate\, author and speaker after her mother experienced great relief from cannabis at the end of her battle with lung cancer. \nShe has a Master of Agriculture from Texas A&M University\, a Bachelor of Science from Tarleton State University and is a graduate of the professional development program Texas Agricultural Lifetime Leadership hosted by the Texas A&M University System’s AgriLife Extension.
URL:https://www.cannabisclinicians.org/event/special-edition-of-journal-club-dr-ethan-russo-nishi-whiteley-on-cannabinoid-hyperemesis-syndrome/
LOCATION:Zoom
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/cannabinoid-hyperemesis-syndrome-ethan-russo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210722T090000
DTEND;TZID=America/Los_Angeles:20210722T100000
DTSTAMP:20260603T221642
CREATED:20210526T130228Z
LAST-MODIFIED:20210526T130228Z
UID:10000083-1626944400-1626948000@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Ethan Russo\, MD & Endocannabinoid Deficiency
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the July edition of “Canna Talk with Frye and Wilson-King” on July 22nd as we explore Clinical Endocannabinoid Deficiency with Ethan Russo\, MD\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Russo and discuss his line of research on the topic of Clinical Endocannabinoid Deficiency and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Russo presented in the SCC Clinical Training Module Clinical Endocannabinoid Deficiency. Learn more about Dr. Russo in the bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nEthan Russo\, MD is a board-certified neurologist\, psychopharmacology researcher\, and author. He is the Founder and CEO of Credo Science. \nPreviously\, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague\, Czech Republic. Medical Director of PHYTECS (2015-2017)\, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system\, and from 2003-2014\, he served as Senior Medical Advisor\, medical monitor and study physician to GW Pharmaceuticals\, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy. \nHe graduated from the University of Pennsylvania (Psychology)\, and the University of Massachusetts Medical School\, before residencies in Pediatrics in Phoenix\, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula\, Montana for 20 years in a practice with a strong chronic pain component. In 1995\, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu\, Peru. \nHe has held faculty appointments in Pharmaceutical Sciences at the University of Montana\, in Medicine at the University of Washington\, and as visiting professor\, Chinese Academy of Sciences\, Harvard University\, and Johns Hopkins University. \nHe is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs\, co-editor of Cannabis and Cannabinoids: Pharmacology\, Toxicology and Therapeutic Potential\, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics\, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS\, Women and Cannabis: Medicine\, Science and Sociology\, Cannabis: From Pariah to Prescription\, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters\, and over fifty articles in neurology\, pain management\, cannabis\, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms\, phytopharmaceutical treatment of migraine and chronic pain\, herbal synergy and phytocannabinoid/terpenoid\, serotonergic and vanilloid interactions. \nHe has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-ethan-russo-md-endocannabinoid-deficiency/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210711T100000
DTEND;TZID=America/Los_Angeles:20210711T120000
DTSTAMP:20260603T221642
CREATED:20210621T062606Z
LAST-MODIFIED:20210624T090550Z
UID:10000086-1625997600-1626004800@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: Emerging Indications for Medical Cannabis in Older Adults with Addie Ron\, MD
DESCRIPTION:Join us for our quarterly meeting\, available to all SCC members. Addie Ron\, MD is the featured speaker who will be exploring: Emerging Indications for Medical Cannabis in Older Adults. \nDr. Ron will talk about the major indications for medical cannabis in older adults and share some of his  published and unpublished data\, including real life stories from his practice. Read more about Dr. Ron in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nAddie Ron\, MD is an Israeli physician certified in Geriatrics and Family Medicine. He holds a Master’s degree in Gerontology from Haifa University and completed a Geriatrics fellowship program at Boston University Medical Center. Doctor Ron is a practicing clinician for the last 20 years working at Maccabi Health Services\, the second largest HMO in Israel. In 2017 he entered the cannabis field as well by joining Niamedic as the Medical Director. NiaMedic is a medical data company offering healthcare\, research & consultation services in the cannabis field. As a Geriatrician Doctor Ron focused on treating older adults with Medical Cannabis while collecting data and following hundreds of patients. He recently published with his colleagues a summary article: Medical Cannabis for Older Patients Treatment Protocol and Initial Results (J Clin Med 2019 Nov 1; 8(11):1819.). Doctor Ron continues his practice and research in treating older adults with medical cannabis and is now cooperating with Tikun Olam on summarizing the effect of medical cannabis in reducing polypharmacy.
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-emerging-indications-for-medical-cannabis-in-older-adults-with-addie-ron-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210702T090000
DTEND;TZID=America/Los_Angeles:20210702T100000
DTSTAMP:20260603T221642
CREATED:20201120T170946Z
LAST-MODIFIED:20210616T090325Z
UID:10000063-1625216400-1625220000@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: James Lowder\, MD & Patrick Tso\, PhD on Pharmacokinetics of Cannabinoids & the Lipid Absorption Pathway
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenters:\nJames Lowder\, MD & Patrick Tso\, PhD (bios below) \nTopic:\nPharmacokinetics of Cannabinoids & the Lipid Absorption Pathway \nArticles to be Discussed:\n\nHuman Metabolites of Cannabidiol: A Review on Their Formation\, Biological Activity\, and Relevance in Therapy\nThe Pharmacokinetics and the Pharmacodynamics of Cannabinoids\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nJames N. Lowder\, MD is a board-certified oncologist trained at Case Western Reserve University and Stanford University\, formerly on the staff of the Cleveland Clinic. He has worked in development in the pharmaceutical and diagnostic industry for 30 years and is currently the Chief Medical Officer at Impact-Naturals\, a company developing cannabinoid products for use\nin the enhancement of life-style and personal health. Impact-Naturals aims to produce products which are designed using scientific principles throughout their journey from inception to the hands of the customer. \n  \nPatrick Tso\, PhD graduated in 1978 from the University of Western Australia in Physiology working under Professor W.J. Simmonds. His thesis work was on the role of biliary lecithin on the formation and secretion of chylomicrons. He has worked extensively with the gastrointestinal tract and the lymphatic system (over 40 years)\, especially the absorption of lipids. He has published at length on the formation and secretion of chylomicrons and the process regulating it. He was awarded the Distinguished Research prize from the American Physiological Society for his work on apolipoprotein A-IV. Over the years\, his laboratory has pioneered a number of concepts and approaches to study intestinal fat absorption. He has over 20 years on various NIH Study Sections and 4 years on the NIDDK Council\, and has consulted with a number of pharmaceutical companies including: Ajinomoto of Japan\, Lilly\, Johnson and Johnson\, Pfizer\, Upjohn\, Catalent\, Abbott Nutrition\, Merck\, Sankyo. He is currently the Mary Emery Professor of Pathology.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-july/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210624T090000
DTEND;TZID=America/Los_Angeles:20210624T100000
DTSTAMP:20260603T221642
CREATED:20210526T085834Z
LAST-MODIFIED:20210526T132822Z
UID:10000082-1624525200-1624528800@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis Dosing with Deborah Malka\, MD
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the June edition of “Canna Talk with Frye and Wilson-King” on June 24th as we explore the nuances of cannabis dosing with Deborah Malka\, MD\, PhD.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Malka and discuss how she was introduced to cannabinoid medicine\, what inspired her particular specialty\, and clinical pearls she learned along the way. We will have the opportunity to delve deeper into the topics Dr. Malka presented in her SCC Clinical Training Module Dosage and Delivery of Cannabis Medicine. Learn more about Dr. Malka in the bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nDeborah Malka MD\, PhD is a board-certified specialist in Integrative Holistic Medicine and has made it a priority to support patient empowerment and alternative medicine throughout her career. She has specialized in cannabis medical consultations for the past 15 years\, consulting with over 30\,000 patients to date. Her private practice\, CANNABIS PLUS\, provides medical cannabis and natural health consulting for a national client base via phone or telemedicine appointments. She is both a clinician and an educator in this specialty. She previously served as the medical director for a group of clinics providing medical marijuana evaluations in California\, training 50 physicians and serving over 300\,000 patients. She was the faculty director of the first comprehensive on-line continuing medical education course in Clinical Cannabinoid Medicine sponsored by the Society of Cannabis Clinicians. She is currently completing a manuscript for medical professionals in cannabis medicine. \nPrior to clinical practice\, Dr. Malka completed her PhD in Human Genetics from Columbia University\, and studied both natural and traditional medicine\, with degrees from the University of New Mexico School of Medicine and the Santa Fe College of Natural Medicine. The field of cannabis medicine allows her to integrate her expertise in allopathic medicine\, herbal medicine\, research\, education and patient care. It is her hope that patients will have the experience of finding alternatives to dependence on pharmaceuticals and discover the benefits of choosing healthier options\, including this most powerful herbal medicine\, cannabis.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-dosing-with-deborah-malka-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210618T090000
DTEND;TZID=America/Los_Angeles:20210618T103000
DTSTAMP:20260603T221642
CREATED:20210520T135915Z
LAST-MODIFIED:20210520T153943Z
UID:10000080-1624006800-1624012200@www.cannabisclinicians.org
SUMMARY:Premier Screening of "Synergy": 1st documentary on the Science of Cannabis in Perú
DESCRIPTION:9am PDT /11am Peru/6pm CEST \nJoin the Society of Cannabis Clinicians for the English language premier of the first Peruvian documentary examining the science of cannabis. “Synergy” follows SCC Latin American Chapter member Dr. Max Alzamora and his work with cancer patients in Peru. The documentary highlights the potential benefits of cannabis in oncology\, the long regulatory process in the country\, and future aspirations to improve access to medical cannabis. \nAccording to the Center of Cannabis Studies in Peru\, cannabis has the potential to benefit around seven million people throughout the country. However\, only around 10\,000 patients are registered in the national data\, accounting for less than 1% of the population. The documentary acts as a way to help share knowledge about the benefits of cannabis medicine and encourage more research and compassionate laws for the patients of Peru. \nIn this one-time-only opportunity\, the SCC will present Synergy with its subtitles in English for the first time. The event will start with an introduction from Dr. Alzamora discussing the Peruvian experience of cannabis in clinical practice and why he decided to do the documentary. This will be followed by the documentary screening\, with time at the end for questions and answers. The event is free and open to the public. Sign up via the link below and watch the trailer here. \n  \nRSVP >>
URL:https://www.cannabisclinicians.org/event/documentary-screening-medical-cannabis-in-peru-free/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/synergy-cannabis-documentary.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210616T090000
DTEND;TZID=America/Los_Angeles:20210616T110000
DTSTAMP:20260603T221642
CREATED:20210531T075213Z
LAST-MODIFIED:20210609T064954Z
UID:10000085-1623834000-1623841200@www.cannabisclinicians.org
SUMMARY:International Veterinary Cannabis Roundtable Webinar
DESCRIPTION:Topic: Legal Environment & Challenges Around the Globe\nHost: The SCC International Veterinary Cannabis Alliance\nConfirmed Panel Speakers: \n\nDr. Gary Richter (The Veterinary Cannabis Society – USA)\nDr. Patti Mayfield (The Veterinary Cannabis Society – USA)\nDr. Santiago Acosta (Asociación de Medicina Veterinaria Cannabinoide – LATAM)\nDr. Paula Lezcano (Asociación de Medicina Veterinaria Cannabinoide – LATAM)\nDr. Sarah Silcox (Canadian Association of Veterinary Cannabinoid Medicine)\n\nEvent Description:\nAs medicinal cannabis gains popularity and acceptance worldwide\, interest amongst the veterinary professional and pet loving communities is also increasing at an exponential rate. The newly emerging discipline of veterinary cannabis medicine is rapidly growing while traditional higher learning institutions and scientific research communities are struggling to keep up. This gap in education and scientific evidence\, combined with the slow-moving wheels of governmental regulation\, have created a field that is extremely confusing and challenging to navigate. Therefore\, in order to assist veterinary practitioners around the world\, the newly formed International Veterinary Cannabis Alliance is embarking on a series of roundtable discussions to help fill the current gaps in knowledge and expand our collective wisdom. \nThis series will feature internationally recognized veterinary cannabis experts and pioneers from around the globe who will address the various issues the profession is facing in their respective countries. Through solution-oriented discussions\, we aim to share best practices and tools for advancing and defending veterinarians’ rights to discuss cannabis medicine as a treatment option. \nWe will explore various topics including: \n\nNavigating legal challenges\nProduct quality concerns\nResearch studies and clinical trials\nIndividual case reports\nThe nuances of implementing cannabis in practice\nWhat the future holds for veterinary cannabis medicine\nAnd more.\n\nThis first web-based roundtable discussion will feature an international panel of experts who will address the current legal environment surrounding cannabis for veterinarians throughout the world. They will also explore the ramifications of integrating medical cannabis into the practice of veterinary medicine. \nJoin us as we share knowledge\, insight\, and valuable experience in what promises to be an enlightening and informative panel discussion. This inaugural event is free and open to all. \nRSVP >>
URL:https://www.cannabisclinicians.org/event/international-veterinary-cannabis-roundtable-webinar/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/Vet-Medicine-Event-TW-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210604T090000
DTEND;TZID=America/Los_Angeles:20210604T100000
DTSTAMP:20260603T221642
CREATED:20201120T170920Z
LAST-MODIFIED:20210526T080013Z
UID:10000062-1622797200-1622800800@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Cannabis Nomenclature & Product Standardization with Kenzi Riboulet-Zemouli
DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenter:\nKenzi Riboulet-Zemouli (bio below) \nTopic:\nIdentifying a coherent nomenclature cannabis products \nArticle to be Discussed:\n\n‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nKenzi Riboulet-Zemouli is a French-Algerian interdisciplinary researcher and advocate for sustainable drug policy reforms. He co-founded the French NGO NORML France and the think-tank FAAAT. Focused on Action research (matching scholars and citizens) as a catalyser for legal and social changes\, Kenzi has been particularly involved in studying alternative pathways for Cannabis policy reform\, linking international law with local grassroots initiatives. His work articulates around ethics\, human rights aspects\, fair trade components\, and criteria of sustainability of legally-regulated use\, production\, and markets of internationally controlled and/or psychoactive plants\, fungi\, products or substances.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-june/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210527T090000
DTEND;TZID=America/Los_Angeles:20210527T100000
DTSTAMP:20260603T221642
CREATED:20210409T102717Z
LAST-MODIFIED:20210526T130802Z
UID:10000077-1622106000-1622109600@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis & Mental Health with Dr. Zach Walsh
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the May edition of “Canna Talk with Frye and Wilson-King” on May 27th as we explore cannabis and mental health with Zach Walsh\, PhD\, RPsych.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Walsh and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Walsh presented in his two SCC Clinical Training Modules Cannabis & Mental Health 1: PTSD & Schizophrenia and Cannabis & Mental Health 2: Stress\, Depression\, Anxiety & Insomnia. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nZach Walsh\, PhD\, RPsych is a clinical psychologist\, a Research Affiliate with the BC Centre on Substance Use\, and a Professor of Psychology at the University of British Columbia\, where he directs the Therapeutic\, Recreational\, and Problematic Substance Use lab. He has published and presented widely on topics related to cannabis\, psychedelics\, mental health and psychotherapy. He has been lead investigator for several ongoing studies of the therapeutic use of cannabis including a clinical trial of cannabis for PTSD\, and ongoing studies of the impacts of cannabis legalization of cannabis and of cannabis use among Canadian First Nations. Zach has provided invited consultations on medical cannabis use to the Canadian House of Commons and Senate\, the Uruguayan Ministry of Health and other international organizations.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-mental-health-with-dr-zach-walsh/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Bogota:20210510T170000
DTEND;TZID=America/Bogota:20210511T210000
DTSTAMP:20260603T221642
CREATED:20210420T141746Z
LAST-MODIFIED:20210422T101705Z
UID:10000078-1620666000-1620766800@www.cannabisclinicians.org
SUMMARY:Cannabis for Epilepsy in Veterinary Medicine
DESCRIPTION:Español abajo \nThe Latin American Association of Cannabinoid Veterinary Medicine presents a certified academic program created for medical professionals to navigate the use of cannabis for epilepsy in animals. Epilepsy is a one of the most common conditions in veterinary medicine.  The intention of this seminar is to give veterinarians the tools to address this condition from many different angles. \nThe seminar is two days long\, four hours each day. This course will explore epilepsy from a holistic approach with cannabis. Experts in the field of cannabinoid veterinary medicine will describe the science and how this may apply to clinical practice. The course features three members of the SCC Latin America Chapter\, Dr. Santiago Acosta\, Dr. Juan Lock\, and Dr. Jose Massabo. \nCost \n$35 (launch price until April 25th)\n$50 (full price) \nFor more information and to register\, visit the link below. \nSIGN UP >> \n  \nEPILEPSIA Y CANNABIS EN LA CLINICA VETERINARIA \nLa Asociación de Medicina Veterinaria Cannabinoide de Latinoamérica presenta este programa académico certificado de 8 horas creado para comprender una condición que es de una muy alta incidencia en la clínica veterinaria\, la epilepsia. De esta forma estructuramos un programa para médicos veterinarios que permite abordar esta enfermedad desde todos sus flancos. \nLos días 10 y 11 de mayo a a las 17:00 horas Colombia – México tendremos dos jornadas de de 4 horas en las cuales vamos a hacer un recorrido holístico por esta condición y la manera de abordarla con #CannabisMedicinal de la mano de grandes exponentes expertos en cada uno de sus temas. \nVALOR: \nUS$35\n(Precio de lanzamiento hasta abril 25) \nUS$50\n(Precio full) \n  \nINSCRIPCIÓN >>
URL:https://www.cannabisclinicians.org/event/cannabis-for-epilepsy-in-veterinary-medicine/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/cannabis-epilepsy-in-animals.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210507T090000
DTEND;TZID=America/Los_Angeles:20210507T100000
DTSTAMP:20260603T221642
CREATED:20201120T170855Z
LAST-MODIFIED:20210506T113748Z
UID:10000061-1620378000-1620381600@www.cannabisclinicians.org
SUMMARY:Grand Rounds: Clinical Case Presentations
DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nBased on SCC member requests for a Grand Rounds webinar to present clinical cases and treatment of these particular patients\, our organization will host a pilot event on Friday\, May 7\, 2021 at 9am PST / 12pm EST. Journal Club will continue in June and be held on the first Friday of every month. \nPresenters:\n\nFrederick Slezak\, MD – Crohn’s Disease & Abdominal Pain: A Case Study\nCarolina Nocetti\, MD – An Integrative Approach to Alzheimer’s Disease Treatment\nKent Crowley\, PharmD – Cannabis Use in the Treatment of Pancreatic Cancer\n\n \nThe SCC provides a safe clinical space for members to have open discussions to share challenges\, observations\, and clinical pearls with cannabinoid-based medicines. This event will provide an opportunity to share clinical case reports from members\, ask questions\, and create an opportunity for a dynamic discussion. \nZOOM LINK >>
URL:https://www.cannabisclinicians.org/event/grand-rounds-clinical-case-presentations/
LOCATION:Zoom
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/event-page-image-template.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210429T120000
DTEND;TZID=America/New_York:20210430T170000
DTSTAMP:20260603T221642
CREATED:20210405T164239Z
LAST-MODIFIED:20210405T164239Z
UID:10000076-1619697600-1619802000@www.cannabisclinicians.org
SUMMARY:National Medical Cannabis Unity Conference
DESCRIPTION:The Americans for Safe Access 9th Annual National Medical Cannabis Unity Conference will begin on April 29\, corresponding to the end of the first 100 days of the new Biden administration. This year’s Americans for Safe Access Unity Conference theme is “No Patient Left Behind”. Despite increasing legal access across the country\, patients still face significant barriers\, and there are many actions both Congress and the Biden-Harris administration can and should take to save lives right now. \nThis is an online conference and does not require travel or accommodations to attend. Just internet access. \nThis online conference will feature panel discussions with question time\, breakout sessions for attendees\, and expert-led workshops. \nRegister >>
URL:https://www.cannabisclinicians.org/event/national-medical-cannabis-unity-conference/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/Screenshot-2021-04-05-at-18.36.46.png
END:VEVENT
END:VCALENDAR